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Scichilone N, La Sala A, Bellia M, Fallano K, Togias A,
Brown RH, Midiri M, Bellia V. The airway response to deep
inspirations decreases with COPD severity and is associated with
airway distensibility assessed by computed tomography. J Appl
Physiol 105: 832–838, 2008. First published July 10, 2008;
doi:10.1152/japplphysiol.01307.2007.—In patients with mild chronic
obstructive pulmonary disease (COPD), the effect of deep inspirations
(DIs) to reverse methacholine-induced bronchoconstriction is largely
attenuated. In this study, we tested the hypothesis that the effective-
ness of DI is reduced with increasing disease severity and that this is
associated with a reduction in the ability of DI to distend the airways.
Fifteen subjects [Global Initiative for Chronic Obstructive Lung
Disease (GOLD) stage I–II: n  7; GOLD stage III–IV: n  8]
underwent methacholine bronchoprovocation in the absence of DI,
followed by DI. The effectiveness of DI was assessed by their ability
to improve inspiratory vital capacity and forced expiratory volume in
1 s (FEV1). To evaluate airway distensibility, two sets of high-
resolution computed tomography scans [at residual volume (RV) and
at total lung capacity] were obtained before the challenge. In addition,
mean parenchymal density was calculated on the high-resolution
computed tomography scans. We found a strong correlation between
the response to DI and baseline FEV1 %predicted
(r2  0.70, P  0.0001) or baseline FEV1/forced vital capacity (r2 
0.57, P  0.001). RV %predicted and functional residual capacity
%predicted correlated inversely (r2  0.33, P  0.02 and r2  0.32,
P  0.03, respectively), and parenchymal density at RV correlated
directly (r2  0.30, P  0.03), with the response to DI. Finally, the
effect of DI correlated to the change in large airway area from RV to
total lung capacity (r2 0.44, P 0.01). We conclude that loss of the
effects of DI is strongly associated with COPD severity and speculate
that the reduction in the effectiveness of DI is due to the failure to
expand the lungs because of the hyperinflated state and/or the paren-
chymal damage that prevents distension of the airways with lung
inflation.
high-resolution computed tomography; methacholine; airway-paren-
chyma interdependence; bronchoprovocation; hyperinflation
THE BENEFICIAL EFFECTS OF deep inspiration (DI) in maintaining
airway caliber have been documented by ample experimental
evidence (6, 7, 12, 14, 23). In healthy humans, DIs reverse the
effects of a direct spasmogen, such as methacholine (MCh) (6,
7, 12, 14, 20), but also protect from these effects when taken
before spasmogen exposure (2, 15). In asthma, the beneficial
effects of DI are reduced or absent (7, 12, 14, 16, 17, 23).
Our laboratory has recently demonstrated that the ability of
DI to reverse the reduction in lung function by MCh is also
attenuated in individuals with even mild chronic obstructive
pulmonary disease (COPD), compared with age-matched
healthy subjects (21). In addition, in patients with COPD, the
loss of this physiological function correlates with the loss of
alveolar attachments on the airways (22). We designed this
study to test the hypothesis that the beneficial effect of DI in
COPD decreases with increasing disease severity. In conjunc-
tion with this hypothesis and with the knowledge that disease
severity is also related to the destruction of airway parenchyma
(13), we further explored whether the impairment of the effect
of DI was associated with inability of a deep inspiratory
maneuver to distend the airways and increase their caliber. We
measured airway caliber using high-resolution computed to-
mography (HRCT), as previously demonstrated in healthy
individuals and asthmatic subjects (4). Using HRCT density,
we also assessed airway parenchymal destruction.
MATERIALS AND METHODS
Subjects
The study protocol conformed to guidelines issued by the Ethics
Committee of the University of Palermo, Palermo, Italy, and all
subjects gave written, informed consent before participating in the
study. We recruited a total of 15 subjects [age: 69  9.9 yr (mean 
SD); range: 53–90 yr], all but one of whom fulfilled the diagnostic
criteria for COPD of the GOLD (Global Initiative for Chronic Ob-
structive Lung Disease) guidelines (10) (Table 1). One subject did not
fulfill the GOLD spirometric criteria for airflow limitation, but he was
a chronic smoker with persistent respiratory symptoms, a lung CO-
diffusing capacity of 58% predicted, and clear radiological evidence
of emphysema on HRCT. Ten subjects were ex-smokers (47  13
pack yr, mean  SD), and five were current smokers (25  13
pack yr, mean  SD). Subjects were recruited from the Outpatient
Clinic for Respiratory Diseases of the University of Palermo. None
had suffered from an upper respiratory infection for at least 4 wk
before evaluation. At the time of the study, all subjects were clinically
stable. Before each study visit, subjects abstained from inhaled,
short-acting -agonists and/or anticholinergic agents for at least 8 h,
or long-acting -agonists for at least 24 h. No subject was using
leukotriene modifiers or methylxanthines. Subjects were ineligible for
the study if they had a history of myocardial infarction, congestive
heart failure, cor pulmonale, or arrhythmia. Subjects were also ex-
cluded if they had a history of asthma.
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Study Design and Methods
Clinical and functional assessments. The study consisted of two
phases. In the first phase, clinical and functional assessments were
performed. The clinical evaluation included a questionnaire that is a
modification of the International Union Against Lung and Tubercu-
losis Disease bronchial symptom questionnaire (1) and a physical
examination. The functional assessment included lung volume deter-
minations by the helium dilution method and evaluation of the ability
of DI to reverse the effects of MCh bronchoprovocation on lung
function. Total lung capacity (TLC), functional residual capacity
(FRC), and residual volume (RV) were determined, and the results
were expressed as a percentage of predicted values.
The effectiveness of DIs was determined using MCh broncho-
provocations, as previously reported (21). First, a series of increasing
single-dose MCh bronchoprovocations were performed on separate
days, at least 24 h apart, until the targeted reduction in lung function
was attained. On each experimental day, baseline lung function
confirmed that the constrictive effect of the previous day’s MCh had
dissipated. The primary outcome in these provocations was the in-
spiratory vital capacity (IVC), and the targeted reduction of this
outcome was 15%. At baseline, three acceptable IVC measurements
were obtained, and the highest value was used for analysis. The
subject was thereafter instructed to abstain from DIs for 20 min, at
which point the MCh dose was delivered. Three minutes later, a single
IVC maneuver was performed. If the single IVC maneuver did not
satisfy the start-of- and end-of-spirometric criteria for acceptability
(30), the test was discarded and repeated on the following day. In the
challenge in which the 15% or greater reduction in IVC from baseline
was reached, the subject was asked to take four consecutive deep
breaths. With the addition of the single DI maneuver that was already
performed as part of the post-MCh spirometry, a total of five DI
maneuvers were performed post-MCh. Immediately after the DIs,
another single IVC maneuver was performed (Fig. 1).
To obtain IVC, subjects expired forcefully from end-tidal volume
to RV and immediately inhaled to TLC. The spirometric measurement
was, therefore, a combined maneuver (a partial followed by a maxi-
mal forced expiratory maneuver), which enabled the IVC to be
determined as the volume of air inhaled from the RV, which is
reached at the end of the partial forced expiration, to the TLC, which
is reached with the immediately ensuing DI. IVC was used in these
studies because it is dependent on the RV reached at the end of the
partial expiratory maneuver and assumes that the effort of the ensuing
inspiration to TLC is reproducible. Thus the DI of the IVC maneuver
does not influence the outcome. The ability of DI to improve IVC after
MCh was calculated using the ratio of the difference between post-DI
IVC and post-MCh IVC over the post-MCh IVC; this was expressed
as a percentage and was termed “effect of DI.” The formula used was:
Effect of DI
post-DI IVC  post-MCh IVC
post-MCh IVC
 100
The combined partial/maximal spirometric maneuver also allows
for determination of forced expiratory volume in 1 s (FEV1) and
Table 1. Demographic and functional characteristics of the subjects
Subjects No. Age, yr FEV1, %predicted FVC, %predicted FEV1/FVC RV, %predicted FRC, %predicted TLC, %predicted %BD (IVC)
1 53 45 97 0.38 113 115 95 5
2 72 29 62 0.31 136 110 122 1
3 60 41 88 0.35 191 185 120 6
4* 61 78 87 0.69 89 73 84 4
5 78 38 79 0.35 152 137 110 0
6 64 53 68 0.59 120 92 86 0
7 81 42 77 0.34 146 137 101 2
8 61 43 63 0.54 94 80 81 3
9 74 49 69 0.46 144 127 99 0
10 69 48 87 0.40 103 100 102 0
11 70 76 88 0.63 82 77 84 13
12† 56 80 77 0.84 114 87 84 17
13 72 84 117 0.52 137 126 124 13
14 71 73 99 0.60 89 85 87 9
15 90 67 90 0.59 101 95 98 10
Mean  SE 692.6 564.6 833.8 0.510.04 1217.7 1087.8 983.8 4.41.7
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; FEV1/FVC, ratio of FEV1 to FVC; RV, residual volume; FRC, functional residual capacity;
TLC, total lung capacity; %BD (IVC), percent bronchodilation by deep inspirations based on the inspiratory vital capacity. *For subject 4, who is 61 yr old, the
lower limit of normal would be equal to 0.70. †Subject 12 is a long-term smoker whose symptoms were not explained by a comorbid condition, whose lung
CO-diffusing capacity was 59%, and whose high-resolution computerized tomography showed clear evidence of emphysema.
Fig. 1. Schematic of the protocol for methacholine (MCh) bronchoprovocations employed to determine the 15% reduction in inspiratory vital capacity (IVC)
and the effect of deep inspiration. Lung function assessment consists of a partial forced expiration from end-tidal volume to residual volume (RV), followed
immediately by deep inspiration to total lung capacity (TLC) and by another forced expiration to RV. This combination maneuver enables us to measure the IVC
as the difference between the TLC and the preceding RV. Note that a total of five deep inspiration maneuvers were performed after MCh administration and
before the last lung function assessment, because one maneuver was already included in the post-MCh lung function assessment.
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forced vital capacity (FVC). These variables were recorded but were
only used in secondary analyses due to the fact that their outcome is
influenced by the DI of the maximal maneuver; because our study
aimed at examining the effects of DI, it was important that the method
of measurement of the changes induced by MCh is not itself influ-
enced by DI.
MCh (Lofarma, Milan, Italy) was delivered in tidal inhalations
through an ampule-dosimeter (Mefar Elettromedicali, Bovezzo, Italy),
which was activated by the inspiratory effort for 0.5 s at a time. All
spirometric measurements were obtained from a computerized, water-
sealed spirometer (Biomedin, Padua, Italy), which allowed compli-
ance with American Thoracic Society criteria (2a) to be confirmed
online.
Airway imaging. On another occasion, we assessed HRCT changes
in airway caliber with lung inflation, in the absence of pharmacolog-
ically induced airway tone. Each subject underwent HRCT evaluation
within 3 days of the functional assessment. HRCT scans were per-
formed by spiral computed tomography (CT) (multidetector 40 chan-
nels, Brilliance 40, Philips Medical System, Cleveland, OH), with a
setting of 120 kVp, 170 mA, a 2-mm slice thickness, a rotation feed
of 2 cm/s, and a reconstruction interval of 1 mm. Two sets of scans
were obtained: one set at RV and the other at TLC. Subjects first
exhaled to RV and held their breath; the second set of scans was
performed at maximal lung inspiration, at TLC. An initial single-slice
reference scan was acquired before each spiral CT scan set, to locate
a starting position for the spiral CT. The images were reconstructed as
a 16-bit 512  512 matrix, at a window level of 450 Hounsfield
units.
The airway luminal area measurement methodology has been used
and validated in previous studies (4, 5). Scans through identical
airway luminal locations were selected from each of the two sets of
scans (RV and TLC) for each subject using adjacent landmarks, such
as airway bifurcations or accompanying vessels. The HRCT images
were analyzed by using the airway analysis module of the Volumetric
Image and Display Analysis software package (Department of Radi-
ology, University of Iowa). The airway luminal area was measured for
each airway at RV and TLC. The choice of RV, rather than FRC, as
the low volume at which to measure airway areas was made because
we were concerned that, due to the expected hyperinflation, the
change in airway area from FRC to TLC would be blunted to such an
extent that it would not be possible to draw any conclusions from our
study. Changes in airway areas were calculated as the ratio of the
difference in the airway luminal areas at TLC and at RV divided by
the area at RV. For nomenclature of the HRCT measurements of the
airways, we arbitrarily divided the airways by their diameter at RV in
three groups: small (3 mm in diameter), medium (3–5 mm in
diameter), and large (5 mm in diameter) airways. Notably, this
airway nomenclature, as defined in the context of the HRCT, is not the
same as histologically defined airways, because all of the airways we
can measure by HRCT are conducting airways. An example of
matched and measured airways on HRCT scans is shown in Fig. 2. A
value of airway area change was obtained for small, medium, and
large airways. Similarly, airway wall thickness values were obtained
for each group of airways. Airway wall thickness was measured by
randomly drawing at least three lines through the airway wall. The
software program automatically measuring the pixel intensity, and the
inflection points of the pixel intensity represent the edges of the inner
and outer airway wall perimeters.
In addition, we measured lung parenchymal density on the HRCT
scans as an estimate of parenchymal damage. Six regions of interest
were placed on each scan where an airway was also measured on the
right and left side: one each in the anterior, middle, and posterior part
of the parenchyma away from any airways or vessels. An average
Hounsfield unit for all of the regions of interest for each subject was
calculated.
Data analysis. Data were analyzed by paired t-test, as well as by
simple linear and stepwise multiple regressions, where appropriate, as
indicated below. All data analyses used JMP IN 5.1 software (SAS
Institute, Cary, NC). Significance was accepted at a two-tailed level of
P  0.05. Data are presented in the text as means  SE values.
RESULTS
The demographics, lung function characteristics, and the
DI-induced ability to reverse the effects of MCh on IVC for all
subjects who participated in the study are depicted in Table 1.
According to the GOLD guidelines for classification of sever-
ity (10), six subjects belonged to the mild-to-moderate severity
group (stage I–II), and eight subjects were classified as having
severe or very severe COPD (stage III–IV). As mentioned
before, one individual (subject 12) with no airflow limitation
but with a history of smoking habit, dyspnea on exertion in the
absence of any comorbid condition, and radiological findings
of emphysema was also included in the study.
By definition, FEV1 %predicted was significantly lower in
the individuals who belonged to the stage III–IV group as
Fig. 2. High-resolution computed tomography (HRCT) images, one obtained
at RV (A) and the other at TLC (B), in which examples of matched and
measured airways are indicated by the arrows.
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opposed to stage I–II (42  2.2 vs. 73  3.9%; P  0.0001;
mean  SE). FVC %predicted was 78  4.4% in the stage
III–IV and 89  7.0% in the stage group I–II (P  0.17), and
the FEV1-to-FVC ratio (FEV1/FVC) was 0.39  0.03 and
0.64  0.04 in stages III–IV and I–II, respectively (P 
0.0001). Also, the RV %predicted and the FRC %predicted
were higher in the subjects with more severe disease (for RV
%predicted: 135  11 vs. 105  7.5%, P  0.04; for FRC
%predicted: 124  11 vs. 91  6.7%, P  0.02; stage III–IV
vs. stage I–II, means  SE).
We assessed the effect of DI in reversing the induced
bronchoconstriction. The overall reduction in IVC from base-
line in the absence of DIs in the single-dose MCh broncho-
provocation protocol was 25  3.8%. The corresponding
reduction in FEV1 from baseline was 15  3.4%. In one
subject with very severe disease and two subjects with severe
disease, the bronchoprovocation was stopped, for safety rea-
sons, when subjects reached a reduction in IVC equal to 10, 11,
and 13%, respectively, but the protocol was carried on with the
DI component. As we have previously demonstrated, in the
subject group as a whole, the effect of DI was very low, 4.4 
1.7%. Notably, three subjects had negative indexes, as the DIs
after MCh caused further reductions in IVC.
The impairment of the effectiveness of DIs was associated
with the severity of COPD. The effectiveness of DIs, based on
IVC, correlated with baseline FEV1 %predicted (r2  0.70,
P  0.0001) (Fig. 3) and FEV1/FVC (r2  0.57, P  0.001).
The relationship between the effect of DI and FVC %predicted
did not reach statistical significance (r2  0.20, P  0.11). In
addition, a significant inverse relationship was found between
indexes of hyperinflation, such as RV %predicted and FRC
%predicted, and the effect of DI (r2  0.33, P  0.02 and
r2  0.32, P  0.03, respectively). We also calculated the
effect of DIs on the basis of the FEV1 in addition to the IVC.
In this analysis, we only utilized the 10 subjects who had more
than 10% MCh-induced reduction in FEV1 from baseline, in
the absence of DIs, because our laboratory has previously
shown that, if the reduction in FEV1 is small, the effect of DI
becomes difficult to detect (15). The FEV1-based effect of DI
in these subjects was 5.7  1.8%. Contrary to our finding with
the IVC-based effect of DI, the FEV1-based effect did not
correlate with the severity of baseline airway obstruction ex-
pressed as FEV1 %predicted (r2  0.06, P  0.52).
The HRCT-determined mean parenchymal density, mea-
sured at RV, correlated with the effectiveness of DIs (r2 
0.30, P  0.03) (Fig. 4A). The lower the mean parenchymal
density (i.e., lung hyperinflation or lung destruction), the less
effective the DIs. In addition, the change (reduction) in paren-
chymal density from RV to TLC was positively correlated with
the effect of DI (r2 0.42, P 0.01) (Fig. 4B). In other words,
the greater the ability to inflate the lungs with DI, the more
effective the DI-induced reversal of the lung function impair-
ment caused by MCh. Interestingly, the three individuals in
whom DIs led to worsening of IVC after MCh (marked with
triangles in Fig. 4) were among the subjects with the lowest
parenchymal density at RV and those with smallest reduction
in parenchymal density from RV to TLC.
A total of 233 airways were matched and measured on the
HRCT scans (range: 2.0–17.8 mm in diameter at RV). For all
airways, lung inflation from RV to TLC increased the average
airway area by 49  4.3% (mean  SE). As expected, the
relative increase in airway area was higher for the small
airways (74 7.7%) as opposed to the medium (52 6%) and
large (17  8%) airways (P  0.0001).
Overall, airway area changes from RV to TLC did not
correlate with FEV1 %predicted (r2 0.02, P 0.57) nor with
FEV1/FVC (r2  0.01, P  0.72). However, when airway area
changes were analyzed separately according to their baseline
caliber, changes in the large airways, but not in the medium
and small airways, were significantly associated with FEV1
%predicted (r2  0.58, P  0.002) and FEV1/FVC (r2  0.34,
P  0.03) (Fig. 5, A and B, respectively). In addition, a
relationship that did not reach statistical significance was
observed between the RV-to-TLC-induced changes in the area
Fig. 3. Correlation between baseline lung function expressed as forced expi-
ratory volume in 1 s (FEV1) %predicted and the improvement in IVC by deep
inspirations after MCh-induced bronchoconstriction.
Fig. 4. A: correlation between the improve-
ment in IVC by deep inspirations after MCh-
induced bronchoconstriction and the lung pa-
renchymal density, as assessed by HRCT.
B: correlation between the improvement in
IVC by deep inspirations after MCh-induced
bronchoconstriction and the changes in the
parenchymal density. Parenchymal density
was measured in the HRCT scans performed
at RV. The triangles represent the three sub-
jects in whom deep inspirations led to reduc-
tion in IVC. HU, Hounsfield unit.
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of the large airways and changes in parenchymal density (r2 
0.23, P  0.08).
Overall, the change in airway areas by DI was not associated
with the beneficial effect of DI against MCh (r2  0.03, P 
0.54). Again, however, large airway area changes were signif-
icantly associated with the effects of DI (r2  0.44, P  0.01)
(Fig. 6), whereas changes in medium and small airway areas
were not (r2  0.008 P  0.75 and r2  0.02, P  0.63,
respectively). Airway wall thickness was not associated with
the effect of DIs, either overall or for any airway caliber group.
DISCUSSION
We have shown that the effect of a DI is strongly related to
the severity of COPD, based on various aspects of baseline
lung function and on imaging abnormalities, such as an HRCT-
based index of hyperinflation/parenchymal destruction. In ad-
dition, by applying HRCT methodology to assess changes in
airway lumen following a deep inspiratory maneuver, we have
observed that the ability of DI to reverse the effects of MCh
correlates with the ability of DI to distend large airways. These
novel observations, which extend our laboratory’s previous
finding that the effect of DI is depressed in COPD (21), are
consistent with the concept that the impairment of DI-induced
airway distension and reversal of airway tone may be an
important factor contributing to the severity of COPD.
The importance of DI is well appreciated in physiological
terms, but very few studies have examined it in the clinical
context. A fundamental hypothesis is that DI exerts its effects
by stretching airway walls. The mechanisms through which
airway stretch may result in the beneficial effects of DI are not
known, but may include the generation of neural reflexes,
release of mediators altering the ASM contractility or, simply,
ASM stretch, which can directly influence the functional state
of the contractile apparatus (9, 11, 19). For stretch to be exerted
on the airway wall, the anatomic and functional interdepen-
dence between the lung parenchyma and the airways needs to
be intact. In COPD, alveolar attachments on airway walls are
progressively destroyed, and this is expected to impact on the
ability of lung inflation by DI to stretch the airways. In fact, we
have previously reported a correlation between loss of alveolar
attachments and reduction in the beneficial effects of DI (22).
In individuals with more severe emphysema, a DI could even
lead to bronchoconstriction, as we have previously described in
COPD subjects (21). Indeed, when the airways are decoupled
from the surrounding parenchyma, the airway response to a DI
may convert from dilatory to constrictive (18), most probably
because of the reduced load that is offered to the airway
smooth muscle by damaged lung parenchyma.
The present study shows that, in COPD, the ability of DIs to
reverse the effect of MCh decreased significantly with de-
creased lung function. The most striking relationship we ob-
served was that baseline FEV1 %predicted accounted for 77%
of the variance of the DI effect. In COPD, reduced baseline
FEV1 results from loss of elastic recoil, hyperinflation, and
increased airway tone. Airway wall thickening may also play a
small role (25). As will be discussed below, the same factors
are probably responsible for the reduction of the effectiveness
of DIs. Furthermore, it is possible that the reduced effective-
ness of a DI per se can lead to increased airway tone. Given the
common upstream pathophysiological mechanisms and the
direct interaction, it was not surprising why such a strong
association between FEV1 %predicted and the DI effect was
observed.
Baseline functional and radiological descriptors of air trap-
ping and lung hyperinflation, such as RV %predicted and FRC
%predicted, as well as an HRCT-based index of parenchymal
density, also correlated with the effect of DI, with greater
hyperinflation and reduced density predicting a reduction in the
DI effect. In the hyperinflated state, the ability to generate high
transpulmonary pressure is severely decreased, leading to di-
minished radial traction and distension of the airways; this can
reduce the DI effect. In support of this concept, Brown and
Mitzner (5) and Salerno et al. (20) have shown that the
Fig. 5. Correlation between baseline lung
function, expressed as FEV1 %predicted (A),
and correlation between baseline lung func-
tion, expressed as FEV1-to-forced vital capac-
ity (FVC) ratio (B) and the changes in the
large airways areas induced by a single deep
inspiratory maneuver.
Fig. 6. Correlation between the improvement in IVC by deep inspirations after
MCh-induced bronchoconstriction and the changes in the large airways areas
induced by a single deep inspiratory maneuver as measured by HRCT.
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magnitude of lung inflation during a DI has a major effect on
subsequent airway size. This is also confirmed by in vitro
studies (9, 11). In particular, Salerno and colleagues demon-
strated that the attenuation of induced bronchoconstriction by
applied stretch is linearly associated with the stretch’s ampli-
tude. The authors also confirmed that the beneficial effect of
lung inflation is more evident on RV than on partial flow,
suggesting that small airways are more susceptible to stretch-
induced changes. It is, therefore, not surprising that failure to
expand the lungs due to the hyperinflated condition would be
one of the major determinants of the loss of the beneficial
effect of DI.
A major finding of this study was that the capacity of DI to
reverse the effects of MCh was related to its ability to distend
the airways. This finding advances our understanding of the
function of DI, as it offers strong support to the hypothesis that
the ability of DI to reverse induced tone depends on the stretch
exerted on airway walls. The relationship between airway
stretch and the functional effect of DI may be complicated, and
this correlation, albeit quite impressive, does not unveil poten-
tial important intermediary interactions. As discussed earlier,
airway stretch may activate various mechanisms, including
alterations in ASM contractility. In this respect, the fact that
five deep breaths were used to reach an optimal functional
effect (15), whereas airway distensibility was assessed with a
single deep inspiratory maneuver (scanning at RV and TLC),
may further confound this relationship. In COPD, reduced
ability of DIs to distend the airways probably reflects the loss
of airway-parenchyma interdependence that results from pa-
renchymal damage (22). However, as discussed above, paren-
chymal damage also leads to hyperinflation, which can further
interfere with the ability of DI to distend the airways. Another
factor that interferes with airway distensibility is smooth mus-
cle tone. Previous work in humans (4) and animals (3) has
demonstrated that increased airway smooth muscle tone re-
duces the ability to pull open the airways with lung inflation. It
is important to note that, in our study, airway distensibility by
a DI was assessed at baseline and not after the administration
of MCh. It is possible that, under the presence of induced tone,
the correlation between the effects of DI on lung function and
on airway area might have been different; we expect it to have
been stronger. However, from a safety and technical perspec-
tive, it would have been quite challenging to obtain HRCT
measurements at RV and TLC in subjects with severe COPD
following the administration of a spasmogen.
Interestingly, we found that the effect of a DI to reverse
MCh-induced bronchoconstriction was associated with base-
line distensibility by DI of large-, but not small- or medium-
sized, airways. This finding seems somewhat counterintuitive
because, if the DI effect depends on airway-parenchyma inter-
dependence, it should primarily influence the smaller airways
on which alveolar septa exert strong traction. One could
attribute this apparent discrepancy between fact and expecta-
tion to various technical issues, such as the above-described
difference in the circumstances in which the HRCT and the
functional assessment of the effect of DI took place or to the
fact that, in the HRCT protocol, only a single DI takes place vs.
five in the post-MCh assessment of the DI effect. Another
explanation can be that, in COPD, the component of airway-
parenchyma interdependence attributable to the small- and
medium-sized airways is already reduced substantially as a
result of parenchymal damage, so that its influence on airway
distention, as assessed by HRCT imaging, is negligible. Also,
it is important to note that airways smaller than 2-mm diameter
at RV cannot be assessed by HRCT, but these airways are
probably of importance for the outcome in question. Alterna-
tively, the airway-parenchymal interaction involving the large
airways may not be so surprising, since this is the “choke
point” in terms of the smallest total cross-sectional airway area
throughout the entire airway tree and thus the location of the
highest airway resistance to flow in the airway tree (8). As a
result, a distending effect by DI on large airways should have
great impact on relieving airflow obstruction induced by tone.
We measured the ability of DI to reverse the effects of MCh
using two outcomes: the primary being based on IVC and the
secondary on FEV1. Although methodological reasons offer a
compelling argument for the use of IVC in this line of testing
(see MATERIALS AND METHODS), the fact that IVC and FEV1
reflect different aspects of lung function (volume vs. airflow)
justifies the collection of data from both outcomes. In this
study, however, the index of the effect of DI that was based on
FEV1, unlike that based on IVC, did not correlate with the
severity of baseline airway obstruction expressed as FEV1
%predicted (r2  0.06, P  0.52). Regardless of the reason,
this finding attests to a higher discriminatory ability of the
IVC-based index in assessing disease severity. In this context,
it should be mentioned that the increase in RV is considered the
major correlate to dyspnea (24), and that recovery from an
exacerbation of COPD is characterized by an increase in
inspiratory capacity more than by improvements in expiratory
airflows (24).
In conclusion, this work makes two significant contributions
to our understanding of the disease process in COPD, as well
as our understanding of the mechanism of action of DIs. First,
our work demonstrates that, in COPD, the ability to reverse the
effects of MCh by DI is reduced in relation to the severity of
disease. This supports the notion that the loss of the effect of
DI may influence the clinical presentation of COPD. Second,
this work advances our understanding of the reduction in the
ability of DI to reverse airway tone as it demonstrates a strong
relationship between this reduction and large airway distensi-
bility by DI.
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